Contemporary Management of Borderline Resectable and Locally Advanced Unresectable Pancreatic Cancer

Adenocarcinoma of the pancreas remains a highly lethal disease, with less than 5% survival at 5 years. Borderline resectable pancreatic cancer (BRPC) and locally advanced unresectable pancreatic cancer (LAPC) account for approximately 30% of newly diagnosed cases of PC. The objective of BRPC therapy...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Shaib, Walid L., Ip, Andrew, Cardona, Kenneth, Alese, Olatunji B., Maithel, Shishir K., Kooby, David, Landry, Jerome, El-Rayes, Bassel F.
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2016
Assuntos:
Gastrointestinal Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4746088/
https://ncbi.nlm.nih.gov/pubmed/26834159
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0316
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados